Department of Endocrinology and Metabolism, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai Clinical Center for Diabetes, Shanghai Key Clinical Center for Metabolic Disease, Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai, China.
Cardiovasc Diabetol. 2013 Apr 1;12:56. doi: 10.1186/1475-2840-12-56.
Pigment epithelium-derived factor (PEDF) has been proved to be closely correlated with metabolic syndrome (MetS) and its components that are all risk factors of cardiovascular disease and may play a protective role against vascular injury and atherosclerosis. The present study was designed to investigate the relationship between serum PEDF and coronary artery disease (CAD).
A total of 312 consecutive in-patients (including 228 with CAD and 197 with MetS) who underwent coronary angiography were enrolled. Serum PEDF was measured by sandwich enzyme immunoassay and used to carry out multivariate stepwise regression analysis to assess correlation with patient demographic and clinical parameters. Multiple logistic regression analysis was performed to identify factors independently correlated with CAD.
Patients with MetS had significantly higher levels of serum PEDF than non-MetS subjects (11.1(8.2, 14.2) vs. 10.1(7.6, 12.4) μg/mL; P < 0.05). Patients with CAD also had significantly higher serum PEDF than non-CAD subjects (11.0(8.1, 14.2) vs. 10.3(8.1, 12.8) μg/mL; P < 0.05). Triglyceride (TG), C-reactive protein (CRP), estimated glomerular filtration rate (eGFR), and hypoglycemic therapy were independently correlated with serum PEDF levels, and serum PEDF was independently positively correlated with CAD.
Serum PEDF levels are independently positively associated with CAD in a Chinese population. Elevated PEDF may act as a protective response against vascular damage and subsequent CAD.
色素上皮衍生因子(PEDF)已被证明与代谢综合征(MetS)及其成分密切相关,这些成分都是心血管疾病的危险因素,可能对血管损伤和动脉粥样硬化起到保护作用。本研究旨在探讨血清 PEDF 与冠状动脉疾病(CAD)之间的关系。
共纳入 312 例连续住院患者(包括 228 例 CAD 患者和 197 例 MetS 患者),行冠状动脉造影检查。采用夹心酶联免疫吸附试验测定血清 PEDF,进行多元逐步回归分析,评估与患者人口统计学和临床参数的相关性。采用多因素 logistic 回归分析确定与 CAD 相关的独立因素。
MetS 患者的血清 PEDF 水平明显高于非 MetS 患者(11.1(8.2, 14.2) vs. 10.1(7.6, 12.4) μg/mL;P<0.05)。CAD 患者的血清 PEDF 水平也明显高于非 CAD 患者(11.0(8.1, 14.2) vs. 10.3(8.1, 12.8) μg/mL;P<0.05)。甘油三酯(TG)、C 反应蛋白(CRP)、估算肾小球滤过率(eGFR)和降糖治疗与血清 PEDF 水平独立相关,血清 PEDF 与 CAD 独立正相关。
在中国人群中,血清 PEDF 水平与 CAD 独立正相关。升高的 PEDF 可能作为对血管损伤和随后的 CAD 的保护反应。